TD Asset Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $343K | Sell |
|
|||||
|
2025
Q1 | $859K | Sell |
|
|||||
|
2024
Q4 | $7.54M | Sell |
|
|||||
|
2024
Q3 | $5.48M | Buy |
|
|||||
|
2024
Q2 | $5.05M | Buy |
|
|||||
|
2024
Q1 | $4.4M | Buy |
|
|||||
|
2023
Q4 | $3.98M | Buy |
|
|||||
|
2023
Q3 | $3.39M | Sell |
|
|||||
|
2023
Q2 | $10.4M | Buy |
|
|||||
|
2023
Q1 | $14.4M | Buy |
|
|||||
|
2022
Q4 | $8.01M | Sell |
|
|||||
|
2022
Q3 | $9.62M | Buy |
|
|||||
|
2022
Q2 | $8.61M | Buy |
|
|||||
|
2022
Q1 | $9M | Buy |
|
|||||
|
2021
Q4 | $4.64M | Buy |
|
|||||
|
2021
Q3 | $6.59M | Sell |
|
|||||
|
2021
Q2 | $9.01M | Buy |
|
|||||
|
2021
Q1 | $5.06M | Sell |
|
|||||
|
2020
Q4 | $6.71M | Buy |
|
|||||
|
2020
Q3 | $3.22M | Buy |
|
|||||
|
2020
Q2 | $1.63M | Buy |
|
|||||
|
2020
Q1 | $1.83M | Sell |
|
|||||
|
2019
Q4 | $2.59M | Sell |
|
|||||
|
2019
Q3 | $3.32M | Sell |
|
|||||
|
2019
Q2 | $5.11M | Buy |
|
|||||
|
2019
Q1 | $2.91M | Buy |
|
|||||
|
2018
Q4 | $1.88M | Buy |
|